دورية أكاديمية
أعرض في EDS

Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma: A Retrospective Comparative Study.

التفاصيل البيبلوغرافية
العنوان: Ahmed Versus Baerveldt Glaucoma Drainage Device in Uveitic Glaucoma: A Retrospective Comparative Study.
المؤلفون: Sinha S; Wills Eye Hospital, Glaucoma Research Center., Ganjei AY; Drexel University College of Medicine., McWatters Z; Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA., Lee D; Wills Eye Hospital, Glaucoma Research Center., Moster MR; Wills Eye Hospital, Glaucoma Research Center., Myers JS; Wills Eye Hospital, Glaucoma Research Center., Kolomeyer N; Wills Eye Hospital, Glaucoma Research Center., Mantravadi AV; Wills Eye Hospital, Glaucoma Research Center., Pro MJ; Wills Eye Hospital, Glaucoma Research Center., Razeghinejad R; Wills Eye Hospital, Glaucoma Research Center.
المصدر: Journal of glaucoma [J Glaucoma] 2020 Sep; Vol. 29 (9), pp. 750-755.
نوع المنشور: Comparative Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 9300903 Publication Model: Print Cited Medium: Internet ISSN: 1536-481X (Electronic) Linking ISSN: 10570829 NLM ISO Abbreviation: J Glaucoma Subsets: MEDLINE
أسماء مطبوعة: Publication: <2015- > : Philadelphia, PA : Wolters Kluwer Health, Inc.
Original Publication: New York, N.Y. : Raven Press, c1992-
مواضيع طبية MeSH: Glaucoma Drainage Implants* , Prosthesis Implantation*, Glaucoma/*surgery , Uveitis/*complications, Aged ; Female ; Follow-Up Studies ; Glaucoma/etiology ; Glaucoma/physiopathology ; Humans ; Intraocular Pressure/physiology ; Male ; Middle Aged ; Reoperation ; Retrospective Studies ; Tonometry, Ocular ; Treatment Outcome ; Visual Acuity/physiology
مستخلص: Precis: Baerveldt glaucoma drainage device demonstrated a greater reduction in intraocular pressure (IOP) than Ahmed in patients with uveitic glaucoma. The most common cause of failure was uncontrolled IOP in Ahmed and hypotony in the Baerveldt group.
Purpose: To compare the efficacy and safety of Ahmed and Baerveldt glaucoma drainage devices in uveitic glaucoma.
Materials and Methods: The retrospective comparative study included patients with uveitic glaucoma who underwent Ahmed or Baerveldt glaucoma drainage device implantation with a minimum follow-up of 3 months. Success was defined as IOP ≥6 and ≤21 mm Hg and >20% reduction on 2 consecutive visits after the third month with (qualified success) or without (complete success) medications and no further glaucoma surgery or loss of vision. IOP, number of medications, visual acuity, complications, and interventions were compared between groups.
Results: In total, 137 eyes of 122 patients (67 Ahmed, 70 Baerveldt) were included. The preoperative IOP and number of medications in the Ahmed group (32.7±10.3 mm Hg; 4.1±1.3) were similar to Baerveldt (32.1±10.2 mm Hg; 4.3±1.3; P=0.73, 0.35). These at the last follow-up were (18.1±9.8 mm Hg; 2.1±1) in Ahmed and (12.7±6.9 mm Hg; 1.3±1.3) in Baerveldt groups (P=0.04, 0.01). The Baerveldt had greater IOP reduction (60.3% vs. 44.5%) and complete success rate (30% vs. 9%) with higher complication rate (51.4% vs. 20.9%) (all P≤0.05). The de novo glaucoma reoperation rate was 19% in the Ahmed group and 4% in the Baerveldt group (P=0.006). Hypotony resulted in failure in 7 eyes (10%) in the Baerveldt group and none in the Ahmed group (P=0.013).
Conclusions: Higher complete success rate and significantly greater reduction in mean IOP and number of medications were observed in the Baerveldt group, but with a higher rate of complications including hypotony.
References: Siddique SS, Suelves AM, Baheti U, et al. Glaucoma and uveitis. Surv Ophthalmol. 2013;58:1–10.
Merayo-Lloves J, Power WJ, Rodriguez A, et al. Secondary glaucoma in patients with uveitis. Ophthalmologica. 1999;213:300–304.
Takahashi T, Ohtani S, Miyata K, et al. A clinical evaluation of uveitis-associated secondary glaucoma. Jpn J Ophthalmol. 2002;46:556–562.
Bodh SA, Kumar V, Raina UK, et al. Inflammatory glaucoma. Oman J Ophthalmol. 2011;4:3–9.
Ceballos EM, Beck AD, Lynn MJ. Trabeculectomy with antiproliferative agents in uveitic glaucoma. J Glaucoma. 2002;11:189–196.
Papadaki TG, Zacharopoulos IP, Pasquale LR, et al. Long-term results of Ahmed glaucoma valve implantation for uveitic glaucoma. Am J Ophthalmol. 2007;144:62–69.
Ceballos EM, Parrish RK II, Schiffman JC. Outcome of Baerveldt glaucoma drainage implants for the treatment of uveitic glaucoma. Ophthalmology. 2002;109:2256–2260.
Bao N, Jiang ZX, Coh P, et al. Long-term outcomes of uveitic glaucoma treated with Ahmed valve implant in a series of Chinese patients. Int J Ophthalmol. 2018;11:629–634.
Ozdal PC, Vianna RN, Deschenes J. Ahmed valve implantation in glaucoma secondary to chronic uveitis. Eye (Lond). 2006;20:178–183.
Chhabra R, Tan SZ, Au L, et al. Long-term outcomes and complications of Baerveldt glaucoma drainage implants in adults with glaucoma secondary to uveitis. Ocul Immunol Inflamm. 2019;27:1322–1329.
Almobarak FA, Alharbi AH, Morales J, et al. Intermediate and long-term outcomes of mitomycin C-enhanced trabeculectomy as a first glaucoma procedure in uveitic glaucoma. J Glaucoma. 2017;26:478–485.
Iwao K, Inatani M, Seto T, et al. Long-term outcomes and prognostic factors for trabeculectomy with mitomycin C in eyes with uveitic glaucoma: a retrospective cohort study. J Glaucoma. 2014;23:88–94.
Patitsas CJ, Rockwood EJ, Meisler DM, et al. Glaucoma filtering surgery with postoperative 5-fluorouracil in patients with intraocular inflammatory disease. Ophthalmology. 1992;99:594–599.
Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153:789–803.e782.
Bettis DI, Morshedi RG, Chaya C, et al. Trabeculectomy with mitomycin C or Ahmed valve implantation in eyes with uveitic glaucoma. J Glaucoma. 2015;24:591–599.
Iverson SM, Bhardwaj N, Shi W, et al. Surgical outcomes of inflammatory glaucoma: a comparison of trabeculectomy and glaucoma-drainage-device implantation. Jpn J Ophthalmol. 2015;59:179–186.
Christakis PG, Zhang D, Budenz DL, et al. Five-year pooled data analysis of the Ahmed Baerveldt comparison study and the Ahmed versus Baerveldt Study. Am J Ophthalmol. 2017;176:118–126.
Ramdas WD, Pals J, Rothova A, et al. Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature. Graefes Arch Clin Exp Ophthalmol. 2019;257:143–151.
Chow A, Burkemper B, Varma R, et al. Comparison of surgical outcomes of trabeculectomy, Ahmed shunt, and Baerveldt shunt in uveitic glaucoma. J Ophthalmic Inflamm Infect. 2018;8:9.
Budenz DL, Barton K, Gedde SJ, et al. Five-year treatment outcomes in the Ahmed Baerveldt comparison study. Ophthalmology. 2015;122:308–316.
Christakis PG, Kalenak JW, Tsai JC, et al. The Ahmed versus Baerveldt study: five-year treatment outcomes. Ophthalmology. 2016;123:2093–2102.
Barton K, Gedde SJ, Budenz DL, et al. The Ahmed Baerveldt comparison study methodology, baseline patient characteristics, and intraoperative complications. Ophthalmology. 2011;118:435–442.
Tsai JC, Johnson CC, Kammer JA, et al. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma II: longer-term outcomes from a single surgeon. Ophthalmology. 2006;113:913–917.
Kass MA, Heuer DK, Higginbotham EJ, et al. The ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120:701–713; discussion 829-830.
Allan EJ, Khaimi MA, Jones JM, et al. Long-term efficacy of the Baerveldt 250 mm2 compared with the Baerveldt 350 mm2 implant. Ophthalmology. 2015;122:486–493.
Meyer AM, Rodgers CD, Zou B, et al. Retrospective comparison of intermediate-term efficacy of 350 mm(2) glaucoma drainage implants and medium-sized 230-250 mm(2) implants. J Curr Glaucoma Pract. 2017;11:8–15.
Wang S, Gao X, Qian N. The Ahmed shunt versus the Baerveldt shunt for refractory glaucoma: a meta-analysis. BMC Ophthalmol. 2016;16:83.
Assaad MH, Baerveldt G, Rockwood EJ. Glaucoma drainage devices: pros and cons. Curr Opin Ophthalmol. 1999;10:147–153.
Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate Molteno and Ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers. 2002;33:94–101.
Bochmann F, Azuara-Blanco A. Transcameral suture to prevent tube-corneal touch after glaucoma drainage device implantation: a new surgical technique. J Glaucoma. 2009;18:576–577.
Alfawaz AM, Holland GN, Yu F, et al. Corneal endothelium in patients with anterior uveitis. Ophthalmology. 2016;123:1637–1645.
Kalinina Ayuso V, Scheerlinck LM, de Boer JH. The effect of an Ahmed glaucoma valve implant on corneal endothelial cell density in children with glaucoma secondary to uveitis. Am J Ophthalmol. 2013;155:530–535.
Law SK, Kornmann HL, Giaconi JA, et al. Early aqueous suppressant therapy on hypertensive phase following glaucoma drainage device procedure: a randomized prospective trial. J Glaucoma. 2016;25:248–257.
Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the Ahmed glaucoma valve. Am J Ophthalmol. 2003;136:1001–1008.
Syed HM, Law SK, Nam SH, et al. Baerveldt-350 implant versus Ahmed valve for refractory glaucoma: a case-controlled comparison. J Glaucoma. 2004;13:38–45.
معلومات مُعتمدة: IK6 RX002477 United States RX RRD VA
تواريخ الأحداث: Date Created: 20200627 Date Completed: 20210115 Latest Revision: 20210910
رمز التحديث: 20231215
DOI: 10.1097/IJG.0000000000001583
PMID: 32590449
قاعدة البيانات: MEDLINE
الوصف
تدمد:1536-481X
DOI:10.1097/IJG.0000000000001583